|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1001 to 1100 out of 1201 for Mdm2

0.042s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Publication
First Author: Guerra B
Year: 1998
Journal: FEBS Lett
Title: p53 and the ribosomal protein L5 participate in high molecular mass complex formation with protein kinase CK2 in murine teratocarcinoma cell line F9 after serum stimulation and cisplatin treatment.
Volume: 434
Issue: 1-2
Pages: 115-20
Publication
First Author: Ganguli G
Year: 2003
Journal: Mol Cancer Res
Title: p53-independent functions of MDM2.
Volume: 1
Issue: 14
Pages: 1027-35
Publication
First Author: Klein C
Year: 2004
Journal: Br J Cancer
Title: Targeting the p53-MDM2 interaction to treat cancer.
Volume: 91
Issue: 8
Pages: 1415-9
Publication
First Author: Yamashita M
Year: 2005
Journal: J Biol Chem
Title: Ras-ERK MAPK cascade regulates GATA3 stability and Th2 differentiation through ubiquitin-proteasome pathway.
Volume: 280
Issue: 33
Pages: 29409-19
Publication
First Author: Sánchez-Molina S
Year: 2006
Journal: Biochem J
Title: The histone acetyltransferases CBP/p300 are degraded in NIH 3T3 cells by activation of Ras signalling pathway.
Volume: 398
Issue: 2
Pages: 215-24
Publication
First Author: Marine JC
Year: 2007
Journal: J Cell Sci
Title: MDMX: from bench to bedside.
Volume: 120
Issue: Pt 3
Pages: 371-8
Publication
First Author: Ueda Y
Year: 2008
Journal: FEBS Lett
Title: Small mitochondrial ARF (smARF) is located in both the nucleus and cytoplasm, induces cell death, and activates p53 in mouse fibroblasts.
Volume: 582
Issue: 10
Pages: 1459-64
Publication
First Author: Xiong L
Year: 2007
Journal: J Cell Biol
Title: A novel role for IGF-1R in p53-mediated apoptosis through translational modulation of the p53-Mdm2 feedback loop.
Volume: 178
Issue: 6
Pages: 995-1007
Publication
First Author: Suh SS
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme.
Volume: 109
Issue: 14
Pages: 5316-21
Publication
First Author: Meng X
Year: 2014
Journal: Cancer Res
Title: MDM2-p53 pathway in hepatocellular carcinoma.
Volume: 74
Issue: 24
Pages: 7161-7
Publication  
First Author: Liu S
Year: 2017
Journal: Neurobiol Aging
Title: Pomegranate peel extract attenuates D-galactose-induced oxidative stress and hearing loss by regulating PNUTS/PP1 activity in the mouse cochlea.
Volume: 59
Pages: 30-40
Publication
First Author: Latif AL
Year: 2021
Journal: Nat Commun
Title: BRD4-mediated repression of p53 is a target for combination therapy in AML.
Volume: 12
Issue: 1
Pages: 241
Publication
First Author: Amson R
Year: 2011
Journal: Nat Med
Title: Reciprocal repression between P53 and TCTP.
Volume: 18
Issue: 1
Pages: 91-9
Publication
First Author: Valente LJ
Year: 2016
Journal: Cell Rep
Title: Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells.
Volume: 14
Issue: 8
Pages: 1858-66
Publication
First Author: Khadka P
Year: 2022
Journal: Nat Commun
Title: PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation.
Volume: 13
Issue: 1
Pages: 604
Publication
First Author: Datta B
Year: 1996
Journal: J Biol Chem
Title: p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition.
Volume: 271
Issue: 44
Pages: 27544-55
Publication
First Author: Ramachandran S
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: The RNF8/RNF168 ubiquitin ligase cascade facilitates class switch recombination.
Volume: 107
Issue: 2
Pages: 809-14
Publication
First Author: Lin L
Year: 2005
Journal: Oncogene
Title: topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage.
Volume: 24
Issue: 21
Pages: 3385-96
Publication
First Author: Iwakuma T
Year: 2008
Journal: Oncogene
Title: Mtbp haploinsufficiency in mice increases tumor metastasis.
Volume: 27
Issue: 13
Pages: 1813-20
Publication
First Author: Chang NS
Year: 2005
Journal: J Biol Chem
Title: WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53.
Volume: 280
Issue: 52
Pages: 43100-8
Publication
First Author: Aoyama K
Year: 2021
Journal: Leukemia
Title: PRC2 insufficiency causes p53-dependent dyserythropoiesis in myelodysplastic syndrome.
Volume: 35
Issue: 4
Pages: 1156-1165
Publication
First Author: Suh YA
Year: 2011
Journal: Cancer Res
Title: Multiple stress signals activate mutant p53 in vivo.
Volume: 71
Issue: 23
Pages: 7168-75
Publication
First Author: Terry MR
Year: 2015
Journal: Cell Death Differ
Title: Caspase-2 impacts lung tumorigenesis and chemotherapy response in vivo.
Volume: 22
Issue: 5
Pages: 719-30
Publication
First Author: Xu X
Year: 2001
Journal: Nat Genet
Title: Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
Volume: 28
Issue: 3
Pages: 266-71
Publication  
First Author: Si S
Year: 2018
Journal: Exp Hematol
Title: Hematopoietic insults damage bone marrow niche by activating p53 in vascular endothelial cells.
Volume: 63
Pages: 41-51.e1
Publication
First Author: Eischen CM
Year: 1999
Journal: Genes Dev
Title: Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
Volume: 13
Issue: 20
Pages: 2658-69
Publication
First Author: van Oosterwijk JG
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects of Arf tumor suppressor-deficient mice.
Volume: 114
Issue: 28
Pages: 7420-7425
Publication
First Author: Sugihara E
Year: 2012
Journal: Oncogene
Title: Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor.
Volume: 31
Issue: 23
Pages: 2849-61
Publication
First Author: Silva RL
Year: 2005
Journal: EMBO J
Title: Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye.
Volume: 24
Issue: 15
Pages: 2803-14
Publication
First Author: Eischen CM
Year: 2001
Journal: Mol Cell Biol
Title: Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Volume: 21
Issue: 22
Pages: 7653-62
Publication  
First Author: Han NR
Year: 2019
Journal: J Clin Med
Title: TSLP Exacerbates Septic Inflammation via Murine Double Minute 2 (MDM2) Signaling Pathway.
Volume: 8
Issue: 9
Publication
First Author: Ta VB
Year: 2010
Journal: Blood
Title: Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway.
Volume: 115
Issue: 7
Pages: 1385-93
Publication
First Author: Falcon KT
Year: 2022
Journal: Proc Natl Acad Sci U S A
Title: Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.
Volume: 119
Issue: 31
Pages: e2116974119
Publication
First Author: Carstens MJ
Year: 2004
Journal: J Biol Chem
Title: Cell cycle arrest and cell death are controlled by p53-dependent and p53-independent mechanisms in Tsg101-deficient cells.
Volume: 279
Issue: 34
Pages: 35984-94
Publication
First Author: Morrison JP
Year: 2007
Journal: Toxicol Pathol
Title: N-ethyl-N-nitrosourea (ENU)-induced meningiomatosis and meningioma in p16(INK4a)/p19(ARF) tumor suppressor gene-deficient mice.
Volume: 35
Issue: 6
Pages: 780-7
Publication
First Author: Huang Q
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis.
Volume: 115
Issue: 15
Pages: E3368-E3377
Publication
First Author: Yuan S
Year: 2022
Journal: Leukemia
Title: PHF6 and JAK3 mutations cooperate to drive T-cell acute lymphoblastic leukemia progression.
Volume: 36
Issue: 2
Pages: 370-382
Publication
First Author: Schneeberger VE
Year: 2014
Journal: Carcinogenesis
Title: SHP2E76K mutant promotes lung tumorigenesis in transgenic mice.
Volume: 35
Issue: 8
Pages: 1717-25
Publication
First Author: Singh HP
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors.
Volume: 115
Issue: 40
Pages: E9391-E9400
Publication
First Author: Kon N
Year: 2012
Journal: J Biol Chem
Title: Inactivation of arf-bp1 induces p53 activation and diabetic phenotypes in mice.
Volume: 287
Issue: 7
Pages: 5102-11
Publication
First Author: Cubillos-Rojas M
Year: 2016
Journal: Oncotarget
Title: The HERC2 ubiquitin ligase is essential for embryonic development and regulates motor coordination.
Volume: 7
Issue: 35
Pages: 56083-56106
Publication  
First Author: Ianni A
Year: 2021
Journal: Proc Natl Acad Sci U S A
Title: SIRT7-dependent deacetylation of NPM promotes p53 stabilization following UV-induced genotoxic stress.
Volume: 118
Issue: 5
Publication
First Author: Wang J
Year: 2018
Journal: J Biol Chem
Title: Protein phosphatase 5 and the tumor suppressor p53 down-regulate each other's activities in mice.
Volume: 293
Issue: 47
Pages: 18218-18229
Publication
First Author: Ghosh M
Year: 2009
Journal: J Clin Invest
Title: Essential role of the RNA-binding protein HuR in progenitor cell survival in mice.
Volume: 119
Issue: 12
Pages: 3530-43
Publication
First Author: Pant V
Year: 2016
Journal: Oncogene
Title: Distinct downstream targets manifest p53-dependent pathologies in mice.
Volume: 35
Issue: 44
Pages: 5713-5721
Publication
First Author: Xu Y
Year: 2019
Journal: J Biol Chem
Title: Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53-MDM2 interaction in a hydroxylase-independent manner.
Volume: 294
Issue: 25
Pages: 9949-9958
Publication
First Author: Pant V
Year: 2017
Journal: Oncotarget
Title: Tumorigenesis promotes Mdm4-S overexpression.
Volume: 8
Issue: 16
Pages: 25837-25847
Publication
First Author: Hakem R
Year: 1997
Journal: Nat Genet
Title: Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation.
Volume: 16
Issue: 3
Pages: 298-302
Publication
First Author: Mouraret N
Year: 2013
Journal: Circulation
Title: Activation of lung p53 by Nutlin-3a prevents and reverses experimental pulmonary hypertension.
Volume: 127
Issue: 16
Pages: 1664-76
Publication
First Author: Reed SM
Year: 2014
Journal: PLoS One
Title: NIAM-deficient mice are predisposed to the development of proliferative lesions including B-cell lymphomas.
Volume: 9
Issue: 11
Pages: e112126
Publication
First Author: Li D
Year: 2018
Journal: Cancer Res
Title: Peli1 Modulates the Subcellular Localization and Activity of Mdmx.
Volume: 78
Issue: 11
Pages: 2897-2910
Publication  
First Author: Lam B
Year: 2021
Journal: Cells
Title: High Glucose Treatment Limits Drosha Protein Expression and Alters AngiomiR Maturation in Microvascular Primary Endothelial Cells via an Mdm2-dependent Mechanism.
Volume: 10
Issue: 4
Publication
First Author: Tarocchi M
Year: 2011
Journal: Hepatology
Title: Carcinogen-induced hepatic tumors in KLF6+/- mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation.
Volume: 54
Issue: 2
Pages: 522-31
Publication
First Author: Chen Z
Year: 2017
Journal: Hum Mol Genet
Title: LRRK2 interacts with ATM and regulates Mdm2-p53 cell proliferation axis in response to genotoxic stress.
Volume: 26
Issue: 22
Pages: 4494-4505
Publication  
First Author: Kouzu H
Year: 2022
Journal: J Clin Invest
Title: ZFP36L2 suppresses mTORc1 through a P53-dependent pathway to prevent peripartum cardiomyopathy in mice.
Volume: 132
Issue: 10
Publication
First Author: Bialuk I
Year: 2020
Journal: Biogerontology
Title: IL-6 deficiency attenuates p53 protein accumulation in aged male mouse hippocampus.
Volume: 21
Issue: 1
Pages: 29-43
Publication
First Author: Venkatachalam S
Year: 1998
Journal: EMBO J
Title: Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation.
Volume: 17
Issue: 16
Pages: 4657-67
Publication
First Author: Wang J
Year: 2005
Journal: J Biol Chem
Title: Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
Volume: 280
Issue: 13
Pages: 12766-73
Publication
First Author: Wei Y
Year: 2019
Journal: Mol Cancer Res
Title: p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma.
Volume: 17
Issue: 1
Pages: 186-198
Publication
First Author: Kulkarni S
Year: 2017
Journal: PLoS One
Title: Ribosomopathy-like properties of murine and human cancers.
Volume: 12
Issue: 8
Pages: e0182705
Publication
First Author: Secchiero P
Year: 2008
Journal: Blood
Title: Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells.
Volume: 111
Issue: 3
Pages: 1287-94
Publication
First Author: Harajly M
Year: 2015
Journal: Mol Cell Biol
Title: p53 Restoration in Induction and Maintenance of Senescence: Differential Effects in Premalignant and Malignant Tumor Cells.
Volume: 36
Issue: 3
Pages: 438-51
Publication
First Author: Yu D
Year: 2007
Journal: Blood
Title: p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors.
Volume: 109
Issue: 11
Pages: 4936-43
Publication
First Author: Jensen MR
Year: 2003
Journal: Hepatology
Title: Reduced hepatic tumor incidence in cyclin G1-deficient mice.
Volume: 37
Issue: 4
Pages: 862-70
Publication
First Author: Sun Y
Year: 2015
Journal: Cancer Res
Title: WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma.
Volume: 75
Issue: 23
Pages: 5143-54
Publication
First Author: Eyler YL
Year: 1997
Journal: Mol Carcinog
Title: Downregulation of Waf1, C2, C3, and major histocompatibility complex class I loci within an 18-cM region of chromosome 17 in adenovirus-transformed mouse cells.
Volume: 18
Issue: 4
Pages: 213-20
Publication
First Author: Wadgaonkar R
Year: 1999
Journal: J Biol Chem
Title: Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression.
Volume: 274
Issue: 20
Pages: 13760-7
Publication
First Author: Saintigny Y
Year: 1999
Journal: Oncogene
Title: Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint.
Volume: 18
Issue: 24
Pages: 3553-63
Publication
First Author: Inga A
Year: 2002
Journal: Oncogene
Title: A novel p53 mutational hotspot in skin tumors from UV-irradiated Xpc mutant mice alters transactivation functions.
Volume: 21
Issue: 37
Pages: 5704-15
Publication
First Author: Xu D
Year: 2002
Journal: EMBO J
Title: Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.
Volume: 21
Issue: 15
Pages: 4081-93
Publication
First Author: Melnikova VO
Year: 2003
Journal: Oncogene
Title: Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1/2 MAP kinase.
Volume: 22
Issue: 38
Pages: 5958-66
Publication
First Author: Gottlieb E
Year: 1997
Journal: EMBO J
Title: Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis.
Volume: 16
Issue: 6
Pages: 1381-90
Publication  
First Author: Youssef JA
Year: 2003
Journal: Mol Cancer
Title: Hepatocarcinogenic potential of the glucocorticoid antagonist RU486 in B6C3F1 mice: effect on apoptosis, expression of oncogenes and the tumor suppressor gene p53.
Volume: 2
Pages: 3
Publication
First Author: Dudgeon C
Year: 2006
Journal: Cancer Res
Title: Tumor susceptibility and apoptosis defect in a mouse strain expressing a human p53 transgene.
Volume: 66
Issue: 6
Pages: 2928-36
Publication
First Author: Tang J
Year: 2006
Journal: Nat Cell Biol
Title: Critical role for Daxx in regulating Mdm2.
Volume: 8
Issue: 8
Pages: 855-62
Publication
First Author: Aizu W
Year: 2006
Journal: Biochem Pharmacol
Title: Circumvention and reactivation of the p53 oncogene checkpoint in mouse colon tumors.
Volume: 72
Issue: 8
Pages: 981-91
Publication
First Author: Xue SA
Year: 2008
Journal: Immunology
Title: Generation and characterization of transgenic mice expressing a T-cell receptor specific for the tumour-associated antigen MDM2.
Volume: 124
Issue: 3
Pages: 315-21
Publication
First Author: Cuesta A
Year: 2009
Journal: Biochem J
Title: The tumour suppressor p53 regulates the expression of amyloid precursor protein (APP).
Volume: 418
Issue: 3
Pages: 643-50
Publication
First Author: Feng Z
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: Chronic restraint stress attenuates p53 function and promotes tumorigenesis.
Volume: 109
Issue: 18
Pages: 7013-8
Publication
First Author: Bae S
Year: 2012
Journal: FEBS Lett
Title: TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
Volume: 586
Issue: 19
Pages: 3057-63
Publication
First Author: Pal D
Year: 2012
Journal: Carcinogenesis
Title: Prevention of liver carcinogenesis by amarogentin through modulation of G1/S cell cycle check point and induction of apoptosis.
Volume: 33
Issue: 12
Pages: 2424-31
Publication
First Author: Liu Y
Year: 2013
Journal: Biochem Biophys Res Commun
Title: Overexpression of gankyrin in mouse hepatocytes induces hemangioma by suppressing factor inhibiting hypoxia-inducible factor-1 (FIH-1) and activating hypoxia-inducible factor-1.
Volume: 432
Issue: 1
Pages: 22-7
Publication  
First Author: Wang A J
Year: 2022
Journal: Redox Biol
Title: Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2.
Volume: 52
Pages: 102310
Publication
First Author: He G
Year: 2014
Journal: Mol Cell Biol
Title: AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity.
Volume: 34
Issue: 2
Pages: 148-57
Publication
First Author: Fornari F
Year: 2014
Journal: Mol Cancer Res
Title: p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.
Volume: 12
Issue: 2
Pages: 203-16
Publication
First Author: Leeper NJ
Year: 2013
Journal: Arterioscler Thromb Vasc Biol
Title: Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation.
Volume: 33
Issue: 1
Pages: e1-e10
Publication
First Author: Inoue K
Year: 2016
Journal: Int J Cancer
Title: Transcription factors that interact with p53 and Mdm2.
Volume: 138
Issue: 7
Pages: 1577-85
Publication
First Author: Aiken J
Year: 2016
Journal: FASEB J
Title: Phosphorylation of murine double minute-2 on Ser166 is downstream of VEGF-A in exercised skeletal muscle and regulates primary endothelial cell migration and FoxO gene expression.
Volume: 30
Issue: 3
Pages: 1120-34
Publication
First Author: Barabutis N
Year: 2015
Journal: Am J Physiol Lung Cell Mol Physiol
Title: p53 protects against LPS-induced lung endothelial barrier dysfunction.
Volume: 308
Issue: 8
Pages: L776-87
Publication
First Author: Mulay SR
Year: 2016
Journal: Am J Pathol
Title: Murine Double Minute-2 Inhibition Ameliorates Established Crescentic Glomerulonephritis.
Volume: 186
Issue: 6
Pages: 1442-53
Publication
First Author: Wu G
Year: 2014
Journal: Circulation
Title: LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity.
Volume: 130
Issue: 17
Pages: 1452-1465
Publication
First Author: Inoue K
Year: 2016
Journal: Int J Cancer
Title: Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer.
Volume: 139
Issue: 1
Pages: 33-41
Publication
First Author: Lahav-Baratz S
Year: 2017
Journal: Biochem Biophys Res Commun
Title: The testis-specific USP26 is a deubiquitinating enzyme of the ubiquitin ligase Mdm2.
Volume: 482
Issue: 1
Pages: 106-111
Publication
First Author: Boregowda SV
Year: 2017
Journal: Stem Cells
Title: IP6K1 Reduces Mesenchymal Stem/Stromal Cell Fitness and Potentiates High Fat Diet-Induced Skeletal Involution.
Volume: 35
Issue: 8
Pages: 1973-1983
Publication
First Author: Yu M
Year: 2016
Journal: PLoS One
Title: Exercise Activates p53 and Negatively Regulates IGF-1 Pathway in Epidermis within a Skin Cancer Model.
Volume: 11
Issue: 8
Pages: e0160939
Publication
First Author: Saison-Ridinger M
Year: 2017
Journal: PLoS One
Title: Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy.
Volume: 12
Issue: 12
Pages: e0189051
Publication
First Author: Miao SB
Year: 2017
Journal: Arterioscler Thromb Vasc Biol
Title: Accumulation of Smooth Muscle 22α Protein Accelerates Senescence of Vascular Smooth Muscle Cells via Stabilization of p53 In Vitro and In Vivo.
Volume: 37
Issue: 10
Pages: 1849-1859
Publication
First Author: Klimovich B
Year: 2019
Journal: Proc Natl Acad Sci U S A
Title: Loss of p53 function at late stages of tumorigenesis confers ARF-dependent vulnerability to p53 reactivation therapy.
Volume: 116
Issue: 44
Pages: 22288-22293
Publication  
First Author: Singh S
Year: 2019
Journal: JCI Insight
Title: DNA replication in progenitor cells and epithelial regeneration after lung injury requires the oncoprotein MDM2.
Volume: 4
Issue: 20
Publication
First Author: Levine AJ
Year: 2020
Journal: Nat Rev Cancer
Title: p53: 800 million years of evolution and 40 years of discovery.
Volume: 20
Issue: 8
Pages: 471-480